Category

In the news
Predicine is selected as one of the top 5 liquid biopsy startup companies impacting oncology worldwide. 5 Top Liquid Biopsy Startups Impacting Oncology
Q: ONCE SEQUENCING HAS BEEN VALIDATED AS A CLINICAL SOLUTION VIA TRUSTED WORKFLOWS, AND COINCIDING WITH THE TECHNOLOGICAL DEVELOPMENTS DRIVING COSTS LOWER, WE CAN EXPECT ACCELERATED HUMAN GENOME PROFILING FOR CLINICAL DX. HOW SOON, DO YOU THINK, WILL WE SEE ACCELERATED GROWTH AND WHAT CAN WE EXPECT? A: We will see accelerated human genome profiling...
For almost every cancer, immune infiltrates are prognostic markers for better overall outcome,” says Bernard A. Fox, Ph.D., CEO of UbiVac and Harder Chair for Cancer Research, Earle A. Chiles Research Institute. Predictive biomarkers are indicators of whether a patient should get a specific therapy. The use of such biomarkers has been given various names,...